细胞瘤-话题@MedSci

#细胞瘤#

460篇内容 | 6524人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1476143, encodeId=22ad14e614331, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=知临集团有限公司已获得美国 FDA 批准试验用新药的申请，启动用于治疗神经母细胞瘤的再利用小分子药物 SACT-1 的临床试验, objectType=article, longId=217206, objectId=97c621e2066b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c621e2066b, replyNumber=0, likeNumber=81, createdTime=2021-09-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c621e2066b, moduleTitle=知临集团有限公司已获得美国 FDA 批准试验用新药的申请，启动用于治疗神经母细胞瘤的再利用小分子药物 SACT-1 的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c621e2066b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476142, encodeId=ddd214e61423d, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效, objectType=article, longId=215964, objectId=9597215964de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9597215964de, replyNumber=0, likeNumber=83, createdTime=2021-08-20, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9597215964de, moduleTitle=Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9597215964de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476141, encodeId=333c14e614181, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=侧脑室脑膜瘤于中枢神经细胞瘤的CT密度和MR信号相似，如何鉴别？, objectType=article, longId=215224, objectId=aed321522438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aed321522438, replyNumber=0, likeNumber=63, createdTime=2021-08-05, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aed321522438, moduleTitle=侧脑室脑膜瘤于中枢神经细胞瘤的CT密度和MR信号相似，如何鉴别？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aed321522438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476140, encodeId=770114e6140c7, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, objectType=article, longId=215018, objectId=3aeb21501886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aeb21501886, replyNumber=0, likeNumber=79, createdTime=2021-07-31, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aeb21501886, moduleTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aeb21501886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476139, encodeId=37b814e613989, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展, objectType=article, longId=214727, objectId=0e2e214e2713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2e214e2713, replyNumber=0, likeNumber=78, createdTime=2021-07-25, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2e214e2713, moduleTitle=Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e2e214e2713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476138, encodeId=e63414e61389a, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=J Clin Oncol：三种131I-间碘苯甲基胍方案治疗神经母细胞瘤的缓解率！, objectType=article, longId=214521, objectId=90a9214521fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a9214521fb, replyNumber=0, likeNumber=90, createdTime=2021-07-22, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a9214521fb, moduleTitle=J Clin Oncol：三种131I-间碘苯甲基胍方案治疗神经母细胞瘤的缓解率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a9214521fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476137, encodeId=612f14e613734, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用, objectType=article, longId=214487, objectId=ab1021448eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab1021448eb0, replyNumber=0, likeNumber=95, createdTime=2021-07-22, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab1021448eb0, moduleTitle=Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab1021448eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476136, encodeId=e35114e6136d4, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=JCO：rCOJEC，国际高危神经母细胞瘤患者的**诱导方案, objectType=article, longId=213060, objectId=099721306008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099721306008, replyNumber=0, likeNumber=61, createdTime=2021-06-24, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099721306008, moduleTitle=JCO：rCOJEC，国际高危神经母细胞瘤患者的**诱导方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099721306008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476135, encodeId=2c6d14e613526, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择, objectType=article, longId=212792, objectId=f30c212e92da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f30c212e92da, replyNumber=0, likeNumber=69, createdTime=2021-06-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f30c212e92da, moduleTitle=Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f30c212e92da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476134, encodeId=05f014e613466, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Clin Cancer Res：Zotiraciclib联合替莫唑胺治疗复发性高级别星形细胞瘤, objectType=article, longId=212703, objectId=d538212e033d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d538212e033d, replyNumber=0, likeNumber=78, createdTime=2021-06-15, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d538212e033d, moduleTitle=Clin Cancer Res：Zotiraciclib联合替莫唑胺治疗复发性高级别星形细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d538212e033d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476133, encodeId=0b4714e613376, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=JCO：FOXR2可稳定MYCN蛋白，可作为神经母细胞瘤患者不良结果的独立预测因子, objectType=article, longId=212694, objectId=76ae2126945b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76ae2126945b, replyNumber=0, likeNumber=58, createdTime=2021-06-15, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76ae2126945b, moduleTitle=JCO：FOXR2可稳定MYCN蛋白，可作为神经母细胞瘤患者不良结果的独立预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76ae2126945b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476132, encodeId=857e14e613271, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=JCO：ALK遗传变异在高危型神经母细胞瘤中的发生率及对预后的影响, objectType=article, longId=212691, objectId=a72d21269196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a72d21269196, replyNumber=0, likeNumber=91, createdTime=2021-06-15, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a72d21269196, moduleTitle=JCO：ALK遗传变异在高危型神经母细胞瘤中的发生率及对预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a72d21269196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476131, encodeId=f39e14e61312f, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=JCEM：嗜铬细胞瘤和副神经节瘤患者血浆中儿茶酚胺与体重和糖尿病之间的相关性, objectType=article, longId=212494, objectId=eb8c21249490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb8c21249490, replyNumber=0, likeNumber=96, createdTime=2021-06-10, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb8c21249490, moduleTitle=JCEM：嗜铬细胞瘤和副神经节瘤患者血浆中儿茶酚胺与体重和糖尿病之间的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb8c21249490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476130, encodeId=d50314e61307e, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, objectType=article, longId=212409, objectId=8bc7212409a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bc7212409a0, replyNumber=0, likeNumber=89, createdTime=2021-06-08, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bc7212409a0, moduleTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bc7212409a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476127, encodeId=0b4914e6127c6, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=ASCO-2021速递：胶质母细胞瘤，替莫唑胺额外增加6个治疗周期，无益于总生存期, objectType=article, longId=212408, objectId=4ea821240891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea821240891, replyNumber=0, likeNumber=103, createdTime=2021-06-08, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea821240891, moduleTitle=ASCO-2021速递：胶质母细胞瘤，替莫唑胺额外增加6个治疗周期，无益于总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea821240891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476129, encodeId=9c2214e61292f, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期, objectType=article, longId=212407, objectId=dc0d21240ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc0d21240ed5, replyNumber=0, likeNumber=106, createdTime=2021-06-08, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc0d21240ed5, moduleTitle=ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc0d21240ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476128, encodeId=3a2814e6128cf, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=ASCO-2021速递：复发胶质母细胞瘤，Nivolumab联合标准贝伐单抗可使年龄较大的患者受益, objectType=article, longId=212406, objectId=efa62124062e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efa62124062e, replyNumber=0, likeNumber=97, createdTime=2021-06-08, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efa62124062e, moduleTitle=ASCO-2021速递：复发胶质母细胞瘤，Nivolumab联合标准贝伐单抗可使年龄较大的患者受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efa62124062e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476126, encodeId=7b8214e61260c, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Cancer cell：迄今很大胶质母细胞瘤“地图”，丁莉团揭示致命脑瘤中起关键作用的生物图谱, objectType=article, longId=212108, objectId=f0a321210851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a321210851, replyNumber=0, likeNumber=89, createdTime=2021-06-02, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a321210851, moduleTitle=Cancer cell：迄今很大胶质母细胞瘤“地图”，丁莉团揭示致命脑瘤中起关键作用的生物图谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0a321210851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476125, encodeId=84b914e6125ae, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Cell Death Differ：Arrb2促进HIF-1α降解调控胶质母细胞瘤的发生发展, objectType=article, longId=211715, objectId=51d3211e15d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51d3211e15d2, replyNumber=0, likeNumber=85, createdTime=2021-05-25, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51d3211e15d2, moduleTitle=Cell Death Differ：Arrb2促进HIF-1α降解调控胶质母细胞瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51d3211e15d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1476124, encodeId=e54e14e6124b3, content=<a href='/topic/show?id=2bcee797732' target=_blank style='color:#2F92EE;'>#细胞瘤#</a>, objectTitle=Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！, objectType=article, longId=211379, objectId=1eef2113e93c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eef2113e93c, replyNumber=0, likeNumber=93, createdTime=2021-05-17, rootId=0, userName=spoonycyy, userId=bf5e7252474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eef2113e93c, moduleTitle=Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1eef2113e93c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞瘤

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#细胞瘤#

知临集团有限公司已获得美国 FDA 批准试验用新药的申请，启动用于治疗神经母细胞瘤的再利用小分子药物 SACT-1 的临床试验

2021-09-18

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效

2021-08-20

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

侧脑室脑膜瘤于中枢神经细胞瘤的CT密度和MR信号相似，如何鉴别？

2021-08-05

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究

2021-07-31

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Cell Death Differ：外泌体miRNA miR-101-3p和miR-423-5p可抑制髓母细胞瘤的发生发展

2021-07-25

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

J Clin Oncol：三种131I-间碘苯甲基胍方案治疗神经母细胞瘤的缓解率！

2021-07-22

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Radiology：人工智能在星形细胞瘤DCE MRI药代动力学参数中的应用

2021-07-22

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

JCO：rCOJEC，国际高危神经母细胞瘤患者的**诱导方案

2021-06-24

zhaojie88 (审核中...)

前往app查看评论内容

#细胞瘤#

Nat Commun：p32 CAR-T细胞：胶质母细胞瘤的潜在治疗选择

2021-06-17

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Clin Cancer Res：Zotiraciclib联合替莫唑胺治疗复发性高级别星形细胞瘤

2021-06-15

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

JCO：FOXR2可稳定MYCN蛋白，可作为神经母细胞瘤患者不良结果的独立预测因子

2021-06-15

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

JCO：ALK遗传变异在高危型神经母细胞瘤中的发生率及对预后的影响

2021-06-15

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

JCEM：嗜铬细胞瘤和副神经节瘤患者血浆中儿茶酚胺与体重和糖尿病之间的相关性

2021-06-10

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效

2021-06-08

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

ASCO-2021速递：胶质母细胞瘤，替莫唑胺额外增加6个治疗周期，无益于总生存期

2021-06-08

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期

2021-06-08

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

ASCO-2021速递：复发胶质母细胞瘤，Nivolumab联合标准贝伐单抗可使年龄较大的患者受益

2021-06-08

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Cancer cell：迄今很大胶质母细胞瘤“地图”，丁莉团揭示致命脑瘤中起关键作用的生物图谱

2021-06-02

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Cell Death Differ：Arrb2促进HIF-1α降解调控胶质母细胞瘤的发生发展

2021-05-25

spoonycyy (审核中...)

前往app查看评论内容

#细胞瘤#

Lancet oncol：替莫唑胺辅助治疗可改善放疗后的间变性胶质细胞瘤患者的生存预后！

2021-05-17

科室
- - 订阅+
  - 更多科室
工具
服务